Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

duloxetine api market Companies

Duloxetine is an active pharmaceutical ingredient (API) used in the production of medications that treat depression, anxiety, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain. Several pharmaceutical companies are involved in the manufacturing and supply of Duloxetine API.

*Disclaimer: List of key companies in no particular orderLatest Duloxetine API Companies Update

October 2023: Teva Pharmaceutical Industries, the world's largest Duloxetine API supplier, has partnered with Sanofi, a French pharmaceutical company, to create a medication to treat inflammatory bowel disease. Teva's anti-TL1A medication will receive $1.5 billion in funding from Sanofi, a market leader in immunology. We won't know any intermediate findings until the second half of 2024, as the medicine is still in phase 2 testing at this point. Phase 3 studies for a medicine that treats Crohn's disease and ulcerative colitis are scheduled to commence in 2025, with a possible commercial release in the year 2028.

October 2023: Agreements to purchase minority holdings in Ezerx Health Tech Ltd. and Agatsa Software Ltd. were signed by Sun Pharmaceutical Industries Ltd. in October 2023, making it the top provider of Duloxetine API. The investments are in complementary industries, and the corporation has agreed to buy a minority ownership in the entities. The pharmaceutical behemoth will purchase 37.76% of Ezerx Health Tech and 4.04% of Agatsa Software. After initially agreeing to buy 26.09% of Agatsa Software, Sun Pharma has now boosted its stake in the company by 4.04 percent. After this transaction, the pharmaceutical firm will hold 30.13 percent of a digital diagnostic devices firm still in the early stages of development.

October 2023: Sun Pharmaceutical Industries Ltd, the world's largest producer of Duloxetine API, announced that deuruxolitinib, an oral experimental medication for the treatment of people with moderate to severe alopecia areata, had its new drug application authorized by the US health agency. Sun Pharma has submitted a new medication application to the US Food and medication Administration (USFDA) for consideration of its 8mg twice daily dose of deuruxolitinib, the company said in a statement.

List of Duloxetine API Key companies in the market

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Aurobindo Pharma

Lupin

ZydusCadila

Eli Lilly and Company

Hetero

Apotex Inc.

Shionogi Inc.

Zhejiang Huahai Pharmaceutical Co., Ltd

duloxetine api market Market Highlights:

duloxetine api market Market Size

duloxetine api market Market Trends

duloxetine api market Market Analysis

duloxetine api market Market Share

duloxetine api market Market Highlights:

duloxetine api market Market Trends

duloxetine api market Market Analysis

duloxetine api market Market Share

duloxetine api market Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.